• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cutan Pathol . Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients

tetano

Editor, Senior Moderator
J Cutan Pathol


. 2021 May 12.
doi: 10.1111/cup.14059. Online ahead of print.
Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients


Afsaneh Sadeghzadeh-Bazargan[SUP] 1 [/SUP], Mahdi Rezai[SUP] 2 [/SUP], Niloufar Najar Nobari[SUP] 1 [/SUP], Samaneh Mozafarpoor[SUP] 3 [/SUP], Azadeh Goodarzi[SUP] 1 [/SUP]



Affiliations

Abstract

As a respiratory viral infection caused by a novel coronavirus, COVID-19 became rapidly pandemic within a few months. Despite the wide range of manifestations and organ involvement in COVID-19 patients, the exact pathogenesis of severe and fatal types of COVID-19 and causes involved with the individual base of the disease is not yet understood. Several studies have reported clinical, laboratory and histopathological data in favor of vascular injury in multiple organs of critically ill patients with COVID-19 as a result of hyperactive immune response, inflammation and cytokine storm. Also, both clinical and histopathological evidence points to such vascular involvements in the skin. Given the ease of clinical examinations and skin biopsy and the lower risks of transmission of COVID-19 to healthcare workers, the present review article was conducted to investigate the vascular skin manifestations of COVID-19 patients clinically and/or histopathologically as helpful clues for better understanding the pathogenesis and predicting the prognosis of the disease, especially in severe cases. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Coronavirus; coagulopathy; cytokine; histopathology; inflammation; ischemia; necrosis; severe acute respiratory syndrome coronavirus 2 (SARS-COV-2); skin; skin biopsy cutaneous; skin manifestation; vascular injury; vasculitis; vasculopathy.
 
Back
Top Bottom